Comparative evaluation of F-18 FDOPA, F-18 FDG, and F-18 FLT-PET/CT for metabolic imaging of low grade gliomas
- PMID: 20139821
- DOI: 10.1097/RLU.0b013e3181becfe0
Comparative evaluation of F-18 FDOPA, F-18 FDG, and F-18 FLT-PET/CT for metabolic imaging of low grade gliomas
Abstract
Introduction: We undertook this prospective study to compare amino acid metabolism, glucose metabolism, and proliferation in primary and recurrent low grade gliomas using positron emission tomography (PET)/computed tomography with F-18 FDOPA, F-18 FDG, and F-18 FLT.
Methods: Fifteen patients with newly diagnosed or previously treated low grade gliomas (WHO grade I or II) were subjected to F-18-FDOPA, F-18 FDG, and F-18 FLT PET/computed tomography studies on consecutive days. This included 2 patients in remission as control subjects. Uptake of all the 3 tracers were analyzed visually and quantified using standardized uptake values and tumor to normal (T/N) ratios. The accuracy of all the 3 PET tracers in the detection of newly diagnosed and recurrent low grade gliomas was compared.
Results: F-18 FDOPA was positive in all cases of primary and recurrent low grade gliomas and negative in the patients in remission. Tumor was visualized on F-18 FDG in 7 of 13 cases, F-18-FLT was positive in 4 of 13 cases. Average tumor standardized uptake values max for F-18 FDOPA (5.75 +/- 4.9) and F-18 FLT (1.8 +/- 0.91) was lower than that of F-18 FDG (8.5 +/- 4.4). T/N ratios for F-18-FDOPA (2.3 +/- 0.51) and F-18 FLT (1.8 +/- 0.91) were higher than F-18 FDG (1.03 +/- 0.64) providing good image contrast for tumor detection in positive cases.
Conclusion: F-18 FDOPA scan is superior to both F-18 FLT and F-18 FDG for visualization of primary and recurrent low grade gliomas. F-18-FLT should not be considered for evaluation of recurrent low grade gliomas.
Similar articles
-
18F-FDOPA PET/MRI fusion in patients with primary/recurrent gliomas: initial experience.Eur J Radiol. 2009 Aug;71(2):242-8. doi: 10.1016/j.ejrad.2008.04.018. Epub 2008 May 29. Eur J Radiol. 2009. PMID: 18511228
-
18F-FDOPA PET and PET/CT accurately localize pheochromocytomas.J Nucl Med. 2009 Apr;50(4):513-9. doi: 10.2967/jnumed.108.058396. Epub 2009 Mar 16. J Nucl Med. 2009. PMID: 19289420
-
A multicenter clinical trial on the diagnostic value of dual-tracer PET/CT in pulmonary lesions using 3'-deoxy-3'-18F-fluorothymidine and 18F-FDG.J Nucl Med. 2008 Feb;49(2):186-94. doi: 10.2967/jnumed.107.044966. Epub 2008 Jan 16. J Nucl Med. 2008. PMID: 18199618
-
Diagnostic and grading accuracy of 18F-FDOPA PET and PET/CT in patients with gliomas: a systematic review and meta-analysis.BMC Cancer. 2019 Aug 5;19(1):767. doi: 10.1186/s12885-019-5938-0. BMC Cancer. 2019. PMID: 31382920 Free PMC article.
-
(18)F-labeled positron emission tomographic radiopharmaceuticals in oncology: an overview of radiochemistry and mechanisms of tumor localization.Semin Nucl Med. 2007 Nov;37(6):400-19. doi: 10.1053/j.semnuclmed.2007.08.004. Semin Nucl Med. 2007. PMID: 17920348 Review.
Cited by
-
Differentiating high-grade glioma progression from treatment-related changes with dynamic [18F]FDOPA PET: a multicentric study.Eur Radiol. 2023 Apr;33(4):2548-2560. doi: 10.1007/s00330-022-09221-4. Epub 2022 Nov 11. Eur Radiol. 2023. PMID: 36367578
-
Evaluation of 3'-deoxy-3'-[18F]-fluorothymidine (18F-FLT) kinetics correlated with thymidine kinase-1 expression and cell proliferation in newly diagnosed gliomas.Eur J Nucl Med Mol Imaging. 2013 Jan;40(2):175-85. doi: 10.1007/s00259-012-2275-9. Epub 2012 Nov 15. Eur J Nucl Med Mol Imaging. 2013. PMID: 23229746
-
Recent Update on PET/CT Radiotracers for Imaging Cerebral Glioma.Nucl Med Mol Imaging. 2024 Jun;58(4):237-245. doi: 10.1007/s13139-024-00847-4. Epub 2024 Feb 21. Nucl Med Mol Imaging. 2024. PMID: 38932755 Free PMC article. Review.
-
18F-FDOPA PET/CT for detection of recurrence in patients with glioma: prospective comparison with 18F-FDG PET/CT.Eur J Nucl Med Mol Imaging. 2013 Jul;40(7):1025-35. doi: 10.1007/s00259-013-2384-0. Epub 2013 Mar 23. Eur J Nucl Med Mol Imaging. 2013. PMID: 23525498 Clinical Trial.
-
Diagnostic accuracy of anti-3-[18F]-FACBC PET/MRI in gliomas.Eur J Nucl Med Mol Imaging. 2024 Jan;51(2):496-509. doi: 10.1007/s00259-023-06437-4. Epub 2023 Sep 30. Eur J Nucl Med Mol Imaging. 2024. PMID: 37776502 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical